About ALIVE
ALIVE is a venture capital firm founded in 2020. It is primarily based out of Tel Aviv, Israel. As of Mar 2025, ALIVE has invested in 15 companies. It primarily invests in Series A round in Israel based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and High Tech. Most recently it participated in the $***** Series C round of Navina Overall, ALIVE portfolio has seen 3 acquisitions, namely Wisdo, Cynerio and Innovalve. A lot of funds co-invest with ALIVE, with names like Leumi Partners sharing a substantial percentage of its portfolio. ALIVE has team of 8 people including 3 partners.Key Metrics
ALIVE's List of Top Investments
ALIVE has a portfolio of 15 companies. Their most notable investments are in Vessi Medical and Beyeonics Surgical.Their portfolio spans across Israel, United States and Australia. They have invested in HealthTech, Life Sciences, High Tech and 7 other sectors, across stages such as Series A, Series B and 2 more. Here is the list of top investments by ALIVE:1. Wisdo
Online community platform for multiple health conditions. The platform enables users to connect, share and learn about health-related conditions and receive tips and guidance. It offers a community platform for anxiety, self-care, depression, relationship advice, cancer, diabetes, and more.
Key facts about Wisdo
- Founded Year: 2015
- Location: Ramat Hasharon (Israel)
- Stage: Acquired
- Total Funding till date: $11M
- Employee Count: 36 as on Jun 30, 2026
- Investors: RONA Holdings, ALIVE and 12 Others
- Latest Funding Round: Series A, Jan 06, 2023, $*****
- Highlight: Acquired
_1579513303815.png?format=webp&height=120&width=120){kind=logo}
2. Cynerio
Cynerio provides solutions for health data security. The network-based platform gives data visibility into the function and behavior of every medical device, provides protection to ensure operational availability and patient safety. It continuously discovers and classifies all the connected medical devices maps their network behavior based on the context of their communications. It also detects threats in the healthcare context behavior analysis.
Key facts about Cynerio
3. Medisafe
Provider of digital medication engagement and adherence platform. The system delivers omnichannel support including reminders, drug‑interaction alerts, refill tracking, caregiver sharing, and health measurement logs. It integrates SMS, web, mobile apps, wearables, and voice agents to guide patients through their treatment journey. Designed for pharmaceutical brands, providers, and patients, the platform combines AI‑enabled interventions with analytics and SDK tools for custom branded digital companions and care coordination.
Key facts about Medisafe
- Founded Year: 2012
- Location: Boston (United States)
- Stage: Series C
- Total Funding till date: $51.5M
- Employee Count: 101 as on Jun 30, 2026
- Investors: EG Capital Advisors, Sanofi Ventures and 19 Others
- Latest Funding Round: Series C, Feb 25, 2021, $*****
- Highlight: Editors' Pick
4. ONCOHOST
AI-based oncology therapy plan solution for patients and professionals. The company has developed a proprietary proteomic analysis that can analyze the proteomic changes in the blood sample induced by the patient in response to cancer therapy. The company also provide treatment strategy to improve the effectiveness of therapy. It also provides consultancy services to patients, oncologists, nurses, and pharma companies among others. The company has developed PROphet which is a bioinformatics tool used to identify proteomic patterns related to therapy.
Key facts about ONCOHOST
- Founded Year: 2017
- Location: Binyamina Giv at Ada (Israel)
- Stage: Series C
- Total Funding till date: $43M
- Employee Count: 44 as on Jun 30, 2026
- Investors: ALIVE, Leumi Partners and 5 Others
- Latest Funding Round: Grant (prize money), May 15, 2025, $*****
- Highlight: Editors' Pick
5. Thesis
Provider of personalized nootropics for brain health based on the quiz. The company offers personalized blends of nootropic supplements tailored to unique needs based on quiz and health assessments. It offers nutrition formulations to enhance mental performance and manage stress levels.
Key facts about Thesis
- Founded Year: 2017
- Location: New York City (United States)
- Stage: Series A
- Total Funding till date: $13.5M
- Employee Count: 62 as on Jun 30, 2026
- Investors: Creative Capital, REDO Ventures and 7 Others
- Latest Funding Round: Series A, May 02, 2023, $*****
- Highlight: Editors' Pick
ALIVE's Year-on-Year Investment Trends
ALIVE has invested in 15 companies over the last 6 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 1 investment. Its most recent first time investment was in Vessi Medical and most recent follow-on round was in Navina.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 1 | 1 |
2024 | 1 | 1 | 2 |
2023 | 5 | 0 | 5 |
2022 | 5 | 0 | 5 |
2021 | 3 | 0 | 3 |
2020 | 1 | 0 | 1 |
ALIVE's Investments by Stage
ALIVE has made 5 investments in Series A stage with an average round size of $9.57M, 4 investments in Series B stage with an average round size of $22.1M, 3 investments in Seed stage with an average round size of $4.9M and 3 investments in Series C stage with an average round size of $40M.Stage of entry | No. of Investments |
|---|---|
Series A | 5 |
Series B | 4 |
Seed | 3 |
Series C | 3 |
Note: We have considered here, only first round of investments
ALIVE's Investments by Sector
ALIVE has a diverse portfolio, with companies operating in the HealthTech, Life Sciences, Artificial Intelligence - Industry Applications, Consumer and Enterprise Applications. Notably, it has invested in 15 Tech companies, 11 Enterprise (B2B) companies, 5 Consumer (B2C) companies and at least 3 companies focusing on Software.Sector | No. of Investments |
|---|---|
HealthTech | 7 |
Life Sciences | 7 |
Artificial Intelligence - Industry Applications | 2 |
Consumer | 2 |
Enterprise Applications | 2 |
Others | 11 |
Note: We have considered here, only first round of investments
ALIVE's Investments by Geography
ALIVE has made most investments in Israel (9), followed by United States where it has made 5 investments.Country | No. of Investments |
|---|---|
Israel | 9 |
United States | 5 |
Australia | 1 |
Note: We have considered here, only first round of investments
ALIVE's recent investments
ALIVE has not made any investment in 2026 so far.Here are the most recent investments by ALIVE:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 25, 2025 | Israel | Series C | 8293 | [+2] | |
Jul 23, 2024 | Israel | Series D | 8821 | [+5] | |
Feb 14, 2024 | Israel | Series A | 9255 | ||
Aug 29, 2023 | Israel | Seed | 7650 | [+2] | |
Jul 06, 2023 | Israel | Series A | 8146 |
Acquired companies in ALIVE's Portfolio
3 companies from ALIVE's portfolio have been acquired. The most recent acquisition was Wisdo in Oct 2025 by Talkspace for $*****.Here are ALIVE's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 06, 2025 | Jan 06, 2023 | Series A | 9184 | |
Jul 26, 2025 | May 18, 2021 | Series B | 6597 | |
Jul 15, 2024 | Aug 23, 2020 | Series B | 4245 |
_1579513303815.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of ALIVE
ALIVE has a team of 8 members including 3 Partners, 1 Venture Partner and 2 Principals located in Israel. ALIVE's team does not sit on the board of any company as of now.Here is a list of all team members in ALIVE:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Israel | - | ||
Partner | Israel | - | ||
Partner | Tel Aviv | - | ||
Venture Partner | - | - | - | |
Principal | - | - | ||
Principal | Israel | - |
Co-investors of ALIVE
Over the past 6 years, 114 investors have co-invested in ALIVE's portfolio companies. This includes funds and angels.
- Invested before ALIVE: Pitango, Accelmed and 30 others have invested in rounds before ALIVE. There are 2 companies where Pitango has invested before ALIVE and 1 company where Accelmed has invested before ALIVE.
- Top Co-investors of ALIVE: 71 investors entered a company along with ALIVE. These include investors like Leumi Partners (2 companies).
- Invested after ALIVE: A total of 11 investors have invested in ALIVE's portfolio after their investments. Top Investors include European Innovation Council (1 company), Goldman Sachs (1 company) and Novo Holdings (1 company).
Recent News related to ALIVE
•
Clinical AI Leader Navina Secures $55M Series C Funding Led by Growth Equity at Goldman SachsPR Newswire•Mar 25, 2025•Navina, Goldman Sachs, Vertex Ventures Israel, Grove Ventures and 3 others
•
Navina secures $55M Series C led by Goldman Sachs to expand AI-driven healthcare inteCTech•Mar 25, 2025•Navina, Goldman Sachs, Vertex Ventures Israel, Grove Ventures and 1 other
•
•
Vessi Medial raises $16.5M for cryotherapy for bladder cancerMassDevice•Feb 14, 2024•Vessi Medical, ALIVE, Agriline Products, The Trendlines Group and 1 other
•
Nevia Bio Closes $3M Seed Funding RoundFinSMEs•Aug 30, 2023•Nevia Bio, MindUp, Pitango, ALIVE and 2 others
•
•
Magenta Medical Closes $55 Million Funding RoundMedical Product Outsourcing•Jul 03, 2023•Magenta Medical, Orbimed, Pitango, ALIVE
•
Outliers dba Thesis has filed a notice of an exempt offering of securities to raise $15,391,167.00 in New Equity Investmentintelligence360•May 05, 2023•Thesis, Unilever Ventures, REDO Ventures, ALIVE and 1 other
•
Thesis Raises Another $8.4M to Improve your Cognitive Performance Based on Your Body’s Brain ChemistryAlleyWatch•May 04, 2023•Thesis, Unilever Ventures, REDO Ventures, ALIVE and 1 other
•
Heart pump developer Magenta Medical raises $55MVator•May 03, 2023•Magenta Medical, Orbimed, New Enterprise Associates, Pitango and 1 other
